Literature DB >> 3167404

Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.

I M Marks1, P Lelliott, M Basoglu, H Noshirvani, W Monteiro, D Cohen, Y Kasvikis.   

Abstract

A randomised treatment design for 49 chronically obsessive-compulsive ritualising patients was devised and three controlled comparisons were made. 1. During 7 weeks of self-exposure instructions, clomipramine treatment improved some measures of rituals and depression significantly more than did placebo medication; this effect was transient and disappeared as drug treatment and exposure were continued for a further 15 weeks. 2. During 11-16 weeks of clomipramine treatment, self-exposure instructions yielded highly significantly more patient improvement than did anti-exposure instructions on nearly all measures of rituals and some of social adjustment. 3. Adding therapist-aided exposure (1.3 hours) to self-exposure instructions (3 hours) after 8 weeks had a barely significant transient effect of dubious clinical value, which was lost by the end of exposure (at week 23) and during follow-up assessments to week 52. We conclude that of the three therapeutic factors tested, self-exposure was the most potent; clomipramine played a limited adjuvant role, and therapist-aided exposure a marginal one.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167404     DOI: 10.1192/bjp.152.4.522

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Phobias and related anxiety disorder.

Authors:  I Marks
Journal:  BMJ       Date:  1991-05-04

Review 2.  Serotonin selectivity for obsessive compulsive and panic disorders.

Authors:  S A Montgomery; T Bullock; N Fineberg
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

3.  Talk that works: the rise of cognitive behaviour therapy.

Authors:  G Andrews
Journal:  BMJ       Date:  1996-12-14

4.  Obsessive-compulsive disorder: case study and discussion of treatment.

Authors:  J Turk; I M Marks; J Horder
Journal:  Br J Gen Pract       Date:  1990-05       Impact factor: 5.386

Review 5.  Cognitive behavioral therapy for obsessive-compulsive disorder: an update.

Authors:  Jonathan D Huppert; Martin E Franklin
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

6.  The brain in obsessive-compulsive disorder.

Authors:  P K McGuire
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

7.  An update on the efficacy of psychological therapies in the treatment of obsessive-compulsive disorder in adults.

Authors:  Kathryn Ponniah; Iliana Magiati; Steven D Hollon
Journal:  J Obsessive Compuls Relat Disord       Date:  2013-04-01       Impact factor: 1.677

8.  Behavioural approaches to anxiety disorders.

Authors:  L M Drummond
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

9.  Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.

Authors:  Y Kasvikis; I M Marks
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 10.  Non-union bone fractures.

Authors:  Britt Wildemann; Anita Ignatius; Frankie Leung; Lisa A Taitsman; R Malcolm Smith; Rodrigo Pesántez; Martin J Stoddart; R Geoff Richards; Jesse B Jupiter
Journal:  Nat Rev Dis Primers       Date:  2021-08-05       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.